Based on recent data, Tectonic Therapeutic, Inc. (TECX) shows an Average True Range (ATR) of 1.53 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 472.58K, indicating liquidity. These fundamental metrics provide insight into TECX's underlying financial health and market activity.
Tectonic Therapeutic, Inc. (TECX) technical indicators as of December 23, 2025: the SMA 20 is 7.64%, SMA 50 at 14.13%, and SMA 200 at 7.42%. The RSI 14 value is 60.22, suggesting its current momentum. These technical analysis signals help assess TECX's price trends and potential future movements.
Tectonic Therapeutic, Inc. (TECX) stock performance overview as of December 23, 2025: The 52-week high is $61.07 (currently -64.94% below), and the 52-week low is $13.7 (currently 56.28% above). Over the past year, TECX's performance is -51.91%, compared to the S&P 500's 10.56% change.
According to market data, Tectonic Therapeutic, Inc. (TECX) stock's recent performance metrics show that over the last month, TECX is 14.13%, with a Year-to-Date (YTD) performance of -53.63%. Over the past year, the stock has seen a -51.91% change. These figures summarize TECX's price movements across various periods, reflecting its historical returns.
According to current financial data, TECX stock's P/E (TTM) ratio is -5.91, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for TECX, including P/S (N/A), P/B (1.49), and P/FCF (-6.35), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep